Roni Moya
Clinical pathologist biomedical scientist and designer, internationally renowned and specialized in Innovation, Transplant Immunology, Regenerative Medicine, and Cellular Therapy.
Aim and Scope
Journal of Stem Cell Research (ISSN: 2582-8797) (Crossref DOI Prefix 10.52793) (H-Index: 2) (Impact Factor: 1.28) is open access, peer-reviewed journal publishing papers of high quality on the biological aspects of stem cell research. The journal publishes high-grade open access research articles, clinical trials, Reviews, Mini Reviews, Perspectives/Commentaries, Case report, Editorials, Letter to the editor, Short communication, Opinion, Book review, and other special featured articles related to the field of Stem Cell & Research.
Journal of Stem Cell Research covers all aspects of stem cell research ranging from molecular biology and cell biology to tissue regeneration and stem cells to translational research.
The journal aims to provide the authors with an efficient and courteous editorial platform. The authors can be assured of an expeditious publishing process. In this regard, the journal also provides advanced online posting of the accepted articles. The Journal of Stem Cell Research ensures barrier-free, open-access distribution of its content online and thus, helps in improving the citations for authors and attaining a good impact factor.
Submit the manuscript as an e-mail attachment to the Editorial Office at regenerativebiology@genesispub.org or regenerativebiol@genepub.org
Ownership and Management
Journal of Stem Cell Research is owned and published by Genesis Scientific Publications, a privately held academic publishing company based in Chandigarh, India.
Genesis Scientific Publications is responsible for the journal’s production, online hosting, digital archiving, and distribution.
The journal maintains full editorial independence. All editorial decisions, including peer review, article acceptance, and publication, are made solely by the editorial team in accordance with international publishing ethics and best practices.
Contact: contact@genesispub.org
Publisher Website: https://www.genesispub.org/
Responsible Person: Editor-in-Chief: Roni Moya
Indexing and Abstracting
© 2023 Genesis Scientific Publications | Open Access | Licensed under CC BY 4.0
Clinical pathologist biomedical scientist and designer, internationally renowned and specialized in Innovation, Transplant Immunology, Regenerative Medicine, and Cellular Therapy.
Division of Maxillofacial Surgery, Royal College of Surgeons, UK
Professor and Director, Department of Biological Sciences and Public Health Sciences, Clemson University, USA
Professor and Chief of the Developmental and Regenerative Biology Thematic Research Program at the School of Biomedical Sciences, Chinese University of Hong Kong
Cellular and Biocellular Regenerative Medicine, Missoula, USA
Director, Veterinary Regenerative Medicine Laboratory Jockey Club. Buenos Aires, Argentina
Research Assistant Professor, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Consultant Clinical Scientist, Cambridge, UK
Associate Professor, Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China
Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, 85764 Neuherberg, Germany
Department of Plastic, Reconstructive and Aesthetic Surgery, University of the Witwatersrand, Johannesburg, South Africa
Professor & Researcher of Medicinal Chemistry and Drug Discovery, Mansoura University, Egypt
Staff Scientist; Department of Developmental Biology; Washington University School of Medicine in St. Louis, USA
Exogems SA, c/o Biopole, Epallinges, Switzerland
Professor and Director, The Institute of Medical Sciences, Shanxi Medical University, China
Senior Specialist in Clean Room Laboratory and Transplant Stem Cell, Royan Stem Cell Technology Co. and Cord Blood Bank
Clinical pathologist biomedical scientist and designer, internationally renowned and specialized in Innovation, Transplant Immunology, Regenerative Medicine, and Cellular Therapy.
Founder, President & CEO of Auragens, the premier stem cell and research center in the world and located in Panama City, Panama
Scientist, Razi Vaccine and Serum Research Institute, Central region branch, Arak, Iran
Severe burn injuries pose a major ..
Reproductive and regenerative health ..
The interplay between Cellular Stromal ..
Examination of human recombinant ..
Previous reports stated (implied) that ..
Induced pluripotent stem cells (iPSCs) ..
Background Multisystem cerebellar ..
The purpose of this research is to ..
Alzheimer’s disease (AD) is a ..
Among one of the cardinal causes of ..
Back pain lasting for long periods due ..
This review examines prominent peptides ..
Mitochondria‑derived peptides (MDPs), ..
Genesis Scientific Publication is a self-governed as a self-financed organization which aims not to receive any kind of external support from institutions/organization. Hence, the processing charges received from the authors and some academic/corporate sponsors are the sole means of the operation of manuscripts. And for maintenance, the fee is being received namely “Handling Fee”.
Thus, our group is like an open book that can be accessible by anyone who is passionate about journals with any chargeable fee i.e. it’s absolutely free for readers. However, authors are supposed to pay the handling fee which is required for the processing of articles only and no other fee will be charged. And there is a provision made for authors i.e. the payment will only be done after the publication of the manuscript. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge and the charges cover the costs of turning a manuscript into a finished article, and also consists of promotion and distribution fee. Thus, this fee varies accordingly with the extent or type of colored effects, complex equations, extensive editing, and extra elongation of no. of pages of the article, etc.
Moreover, no one can change one's mind or authors as it keeps on changing so authors are responsible for paying 70% of the manuscript handling fee once the article is submitted and accepted in the journal.
The standard processing fee of the journal for all type of articles is mentioned below:
| MANUSCRIPT TYPE | ARTICLE PROCESSING CHARGES | ||
| USD | EURO | GBP | |
| ALL ARTICLE TYPES | 800 | 741 | 637 |
Genesis Journals is committed to maintain the best level of sincerity within the content published in the journal.
Genesis Journals following International Committee of Medical Journal Editors principles on the way to affect acts of misconduct thereby committing to research allegations of misconduct to make sure the purity of research.
The research being reported in articles must be conducted in an ethical manner and must suits all relevant legislation. Authors must refrain from engaging in scientific misconduct.
Authors should present their results honestly and clearly without any fabrication, falsification, or any kind of inappropriate data manipulation. The authors should strive to explain their methods clearly and unambiguously must guarantee the originality of their material and their findings are often confirmed by others.
Authors should provide appropriate acknowledgement and authorship. All authors must have significantly contributed to the research. Authors must refrain from deliberately misrepresenting a scientist’s relationship with published work. Contributors who have made fewer substantial contributions to the research or to the publication are often acknowledged but shouldn’t be identified as authors.
Authors must tell the journal once they have an immediate or indirect conflict of interest with editors or members of the editorial board or International scientific committee.
Genesis Journals employ a double-blind review process. All contributions are going to be initially assessed by the editor. The editor is solely and independently liable for selecting, processing, and deciding which of the articles submitted to the journal meet the editorial goals and will thus be published. Each paper selected is shipped to two independent peer reviewers who are experts in their field and ready to assess the exact qualities of the work. The editor is liable for the final decision regarding whether the paper is accepted or rejected.
The decision to publish a paper will always be measured in accordance with its importance to researchers, practitioners, and potential readers. Editors should make unbiased and independent decision.
The editor’s action and decision are constrained by ethical and legal requirements like its own governing infringement of copyright and plagiarism.
Editors who make final decisions about manuscripts should withdraw from editorial decisions if they need conflicts of interest or relationships that pose potential problems concerning articles into account. The responsibility of the ultimate decision regarding publication are going to be attributed to an editor who doesn’t have any conflicts of interest.
The members of the editorial board ,chief editor, scientific committee, and reviewers shall withdraw in any case of conflict of interest concerning an author or authors, or the content of a manuscript to be evaluated.
The Journal will avoid all conflict of interest between authors, reviewers, and members of the editorial board and International scientific committee.
Each article submitted is the responsibility of one member of the editorial board or of the international scientific committee, who undertakes to have it evaluated by two peers who are experts in the field and who evaluate it anonymously.
Reviewed articles are treated confidentially by journal editorial board members and reviewers
In no case shall a journal and members of the editorial board encourage misconduct of any kind.
Members of the Journal editorial board shall attempt to prevent misconduct by informing authors and reviewers about the moral conduct required of them. Members of the editorial board, scientific committee, and reviewers are asked to remember of all kinds of misconduct to spot papers where research misconduct of any kind has or seems to possess occurred and affect the allegations accordingly.
Where appropriate, journal editors encourage authors to share the info that supports research publications. Editors encourage authors to state the supply of their data during a data statement attached to the submitted article. With the info statement, authors are often transparent about the info they utilized in the article.
All reviewers must know and keep in mind the editorial policy and publication ethics and malpractice statement.
Genesis Journals requires potential reviewers to have scientific expertise or significant work experience in a relevant field. They must have acquired recognized expertise by their peers and recently conducted research work. Potential reviewers should provide personal and professional information which is accurate, and which gives a fair representation of their expertise.
All reviewers must likewise withdraw if they feel their evaluation of the material will not be objective or they know they are unqualified to evaluate a manuscript, or if they understand themselves to be in a conflict of interest.
Reviewed articles are treated confidentially by reviewers and members of the editorial board and international scientific committee.
Reviewers should point out relevant published work which has not yet been cited in the reviewed material. Reviewers are asked to identify papers where research misconduct has or seems to have occurred and inform the editorial board, which will deal with each case accordingly.
The copyright on the original content and intellectual property shall remain with the authors. The authors grant, in exchange for publication in the Journal exclusive licensing of first publication, giving the Journal the right to produce and disseminate the contributions, whether collectively with other articles or individually, and in all media, forms known or to come.
The authors shall guarantee the originality of their material and shall not publish any text that would appear to contradict. Plagiarism and false or intentionally misleading declarations constitute behaviour that is at odds with the ethics of scientific publication.
No significant part of the article shall have been previously published either as an article or as a chapter or be under consideration for publication elsewhere.
If the authors intend to reproduce their article in other publications or for any other purpose and by any means, they must obtain the written authorization of the editorial board.
Articles are published in open access. There are no associated subscriptions or pay-per-view fees. All material is made available under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International license (CC BY-NC-ND 4.0).
Journal’s content is archived in several copies by open edition, a publisher of online, free-access books and journals longer published, open edition maintains free access and will continue to make all archives available online.
The names of authors, reviewers, and collaborators along with the names of their organizations and institutional affiliations, which the Journal may record during its operations, shall remain confidential and shall not be used for any commercial or public ends beyond the signature of the articles published. However, this information may sometimes be required by government grant-giving bodies. The secrecy of the peer review selection shall be maintained when transmitting this information. A list of the names of authors, reviewers, and collaborators and the names of their organizations and institutional affiliations shall be sent with no explicit links between those named.
Genesis Journals may use these lists for its own purposes of request articles, collaboration, or other contributions, notably through occasional e-mails.
The authors retain the copyright of the content and grant the magazine the right to be the first to publish the article. This publication will be made under license, which allows others to share and reproduce the contents as long as the original authorship in the magazine is acknowledged and quoted.
Background Multisystem cerebellar ataxia is a progressive neurodegenerative disorder ..
Induced pluripotent stem cells (iPSCs) have evolved from a transformative discovery in ..
Previous reports stated (implied) that (all) adult stem cells decrease within increasing age of an ..
Examination of human recombinant proteins, morphogenetic proteins, and cell-specific ..
The interplay between Cellular Stromal Vascular Fraction (cSVF), Mesenchymal Stem Cells (MSC), and ..
Reproductive and regenerative health remain pivotal determinants of performance, welfare, and ..
Severe burn injuries pose a major clinical threat due to extensive damage to the integumentary ..